Summaries > Anti-aging > Treatment > The Treatment That Made Me 15 Years Younger...

The Treatment That Made Me 15 Years Younger

https://www.youtube.com/watch?v=TW1Fi5p70cQ

TLDR House of Evolution promotes expensive, experimental longevity treatments—including follistatin gene therapy, Klotho-focused approaches, stem-cell “re-education,” and stem-cell banking—that its founders say may improve muscle, body composition, immune health, and biological-age measures. They envision using these technologies to preserve function into old age and make them more accessible, but many results are preliminary, individual outcomes vary, and the treatments raise regulatory, ethical, and affordability concerns.

Key Insights

Start with Measurable Health Goals, Not Promises of Longevity

Track practical outcomes such as strength, body composition, mobility, and relevant health markers before considering an emerging longevity treatment. The speakers describe biological-age and immune-age test results, but these measures do not establish that a treatment will extend someone’s life. Set specific goals with a qualified clinician and agree in advance on how progress and possible side effects will be assessed. Individual results can vary, and anecdotes should not be treated as typical outcomes.

Understand What a Therapy Does—and How Strong the Evidence Is

Ask for a clear explanation of the treatment’s mechanism, expected duration, risks, and evidence from human studies. In the discussion, follistatin gene therapy is described as using plasmids to prompt temporary protein production without integrating into a person’s genome; the speakers say its effects may last roughly one or two years. Claims about muscle gain, fat reduction, Klotho, or immune-age changes are not equally well established. Distinguish peer-reviewed research and controlled clinical results from preliminary data, provider claims, and individual testimonials.

Review Regulatory Status and Treatment Risks Before Proceeding

Confirm whether a therapy is authorized or considered experimental where you live, and ask who is responsible for medical oversight and follow-up. Some treatments described, including stem-cell “re-education,” are offered in Mexico and may not be covered by insurance. Discuss uncertainties, potential complications, alternatives, and what care is available if something goes wrong. Consider seeking an independent opinion from a clinician who is not selling the treatment.

Focus on Body Composition and Sustainable Health Habits

The speakers emphasize improving muscle and reducing visceral fat rather than focusing only on scale weight. Build a plan around appropriate resistance exercise, adequate nutrition, sleep, and regular clinical monitoring, tailored to your health status. They report changes in lean muscle and body fat among clients receiving follistatin therapy, but those figures are not a guarantee of personal results. Use validated measurements and a clinician’s guidance to interpret changes over time.

Consider Lower-Cost, Better-Established Steps Alongside New Therapies

Before spending heavily on experimental treatments, review established options for addressing your specific health concerns. The discussion mentions gut health and lower-cost interventions, but claims about gluten, glyphosate, microbiome changes, or supplements should be evaluated carefully rather than assumed to apply to everyone. Ask a clinician whether testing or dietary changes are appropriate, and avoid stopping prescribed treatment without medical advice. Compare the likely benefits, costs, and evidence for each option.

Plan for Cost, Access, and Long-Term Follow-Up

Emerging longevity treatments can cost more than $10,000 and may require travel, repeat procedures, or continued monitoring. Ask for a written breakdown of the total cost, including consultations, testing, follow-up care, and management of complications. Confirm how long the treatment is expected to last and what evidence supports repeat treatment. Make decisions based on your health priorities and budget, not on promises that prices will eventually fall or that a therapy will produce “escape velocity.”

Questions & Answers

What is House of Evolution, and what is its goal?

House of Evolution is a membership and concierge project that gives clients access to emerging longevity and human-enhancement treatments, including therapies that may not be widely available or approved in their home countries. Its founders hope that broader awareness and demand will eventually make these treatments more accessible and affordable.

How does follistatin gene therapy work, and does it change a person’s genome?

The therapy uses circular DNA plasmids produced in E. coli. After injection, the plasmids enter cells and prompt them to produce follistatin. The speakers say the plasmids do not edit or integrate into the person’s inherited genome, and that the effects last roughly one or two years before the treated cells and effects disappear.

What results do the speakers report from follistatin gene therapy?

They report average gains of about seven or eight pounds of lean muscle and a one- or two-percentage-point reduction in body fat when treatment is combined with exercise and adequate protein. They also cite an individual whose body fat reportedly fell from 37.9% to 28%. These are reported outcomes, not guarantees for every person.

What is the speakers’ view of biological-age and longevity results?

They cite examples of clients improving aging-related measurements, including one person who went from failing 11 of 12 assessments to having one red result after a year. They also say at least 20% of Unlimited Life clients in the first year reduced their biological age by a year or more, and that AI analysis of biomarkers suggested some clients’ projected life expectancy increased by three or four years. They acknowledge that outcomes vary and that accidents cannot be controlled.

Why do the speakers emphasize visceral fat and body composition?

They argue that visceral fat is an important contributor to chronic disease and aging, so improving body composition matters more than simply reducing weight. They describe member results involving reduced visceral fat and say one gene-therapy treatment appeared to help people lose dangerous fat while gaining muscle.

What is Klotho, and what results are reported for the treatment targeting it?

Klotho is described as a protein associated with kidney health, cognition, neuroplasticity, and libido whose levels tend to decline with age. The speakers cite preliminary results from roughly 50 recipients showing an average threefold increase, including one person whose level rose from 0.9 to 10. They caution that these findings—and claims such as possible IQ increases—are preliminary, and suggest stress may contribute to low Klotho.

What is the stem-cell “re-education” treatment?

As described by the speakers, a person’s white blood cells and stem cells are separated, incubated with cord-blood stem cells for 24 hours while exchanging signaling molecules across a membrane, and then returned to the body. They claim the process may reset or rejuvenate immune cells, but acknowledge the treatment is very early and that average effects are not yet established.

What benefits do the speakers claim for stem-cell re-education?

They say it may reduce autoimmunity and rejuvenate immune function. They cite reported hair regrowth among people with alopecia totalis and suggest that a healthier immune system could support other areas, including muscle, bones, brain function, and defense against infections. These claims are presented as emerging evidence rather than settled conclusions.

What practical limitations and alternatives do the speakers mention for these treatments?

The treatments are described as cutting-edge, costly, and generally not covered by insurance; one treatment reportedly had a two-month waitlist. The speakers hope wider use will lower prices and mention lower-cost options such as low-dose naltrexone or PEA. They also emphasize gut health and discuss possible contributors to gut damage and autoimmunity, including gluten, glyphosate, antibiotics in the food chain, and reduced microbiome diversity.

What future stem-cell developments do the speakers discuss?

They discuss banking bone-marrow stem cells for possible future reprogramming, gene editing, and restoration, and say researchers are working to make stored cells more youthful or give them additional capabilities. They also mention a Boston company growing organoids and heart tissue from a person’s stem cells as a possible alternative to heart transplants, while raising ethical questions about growing body parts.

What is the speakers’ broader vision for aging and access to longevity treatments?

They envision maintaining roughly 90% of a person’s productivity and function into old age, with ongoing rejuvenation rather than a fixed period of peak performance. They argue that people should be able to choose treatments and that access should eventually broaden, while acknowledging ethical concerns, regulatory challenges, uncertainty, and current high costs.

Summary of Timestamps

Dave Asprey and longevity-medicine expert Dr. Tim Cook introduce House of Evolution, a project created with Mark to connect members with emerging longevity and human-enhancement treatments. They cite client results from aging-related assessments, including one person who went from 11 red results out of 12 to just one after a year.

The speakers explain follistatin gene therapy, which is intended to counter age-related muscle loss and anabolic resistance. Dr. Cook says it uses circular DNA plasmids produced in E. coli; after injection, the plasmids prompt cells to make follistatin without editing or integrating into a person’s genome.

They describe reported outcomes and the goal of making advanced treatments more accessible. Asprey says the therapy has been associated with biological-age test results averaging about nine years younger, and notes that partner Mini Circle became a finalist for the $100 million XPRIZE Healthspan competition.

The conversation turns to results reported by Unlimited Life: clinicians say at least 20% of first-year clients reduced their biological age by a year or more. AI analysis of 700 biomarkers reportedly suggests some clients’ projected life expectancy rose by three or four years, though the speakers acknowledge individual variation and risks such as accidents.

The speakers debate access and ethics. House of Evolution aims to offer some treatments that may be unavailable in certain countries for decades, with the hope that increased demand will eventually lower prices. They differ on whether this should be called “democratizing” access, while agreeing that people should have choices and that affordability matters.

They define the goal as preserving function, not simply extending lifespan: ideally, a person would maintain around 90% of their productivity and capability into old age. One speaker rejects the idea of a fixed “peak span” and imagines ongoing rejuvenation, while noting that regulation is not designed for therapies intended to reverse aging.

The speakers discuss the reported duration and body-composition effects of follistatin therapy. They say its effects may last one or two years as treated cells disappear, and cite average gains of roughly seven or eight pounds of lean muscle and a one- or two-percentage-point reduction in body fat, alongside exercise and adequate protein.

They emphasize visceral fat as a risk factor for chronic disease and argue that body composition matters more than weight alone. They cite member reports of reduced visceral fat and increased muscle, while Asprey says his own low visceral-fat reading reflects several practices, including follistatin gene therapy.

Klotho is presented as another potential longevity target because its levels tend to decline with age and it is associated with kidney health, cognition, neuroplasticity, and libido. The speakers cite preliminary results from about 50 recipients, including an average threefold increase, but stress that the evidence—and claims such as possible IQ changes—remains early.

The conversation introduces additional House of Evolution offerings, including a treatment intended to keep Klotho levels elevated and an experimental “stem-cell re-education” procedure. The speakers share individual biological-age and immune-age results but say there is not yet enough data to establish average effects.

They describe House of Evolution as a membership and concierge community for pursuing longevity, energy, and cognition. Treatments can cost more than $10,000, they say, but expanded production could reduce prices. They also characterize Mini Circle’s protein and gene-therapy approaches as temporary rather than changes to inherited genetics.

One speaker recounts personal health challenges, including autism, obesity, arthritis, Hashimoto’s, Ehlers-Danlos, gut issues, and toxic mold exposure, and says a treatment reduced his immune age by 15.2 years. He begins explaining that a patient’s white blood cells and stem cells are separated and exposed to cord-blood stem cells across a membrane.

The speakers explain the experimental re-education process: a person’s cells are incubated with cord-blood stem cells for 24 hours and then returned to the body. They say signaling molecules may help reset immune cells and reduce autoimmunity, citing reported hair regrowth in people with alopecia totalis and referring to published studies.

They compare the treatment’s proposed effects with animal research in which exposure to a younger biological environment appeared to rejuvenate an older transplanted heart. They suggest a healthier immune system could support muscles, bones, and brain function, and improve defenses against infections and other conditions, while presenting these as potential benefits.

The treatment is described as cutting-edge, costly, generally not covered by insurance, and available through House of Evolution in Mexico. As more accessible options, the speakers mention low-dose naltrexone and PEA, and highlight gut health and possible contributors to gut damage, including gluten, glyphosate, antibiotics, and reduced microbiome diversity.

House of Evolution offers membership and concierge access to emerging therapies, and the speakers are exploring bone-marrow stem-cell banking for future gene editing and restoration. They emphasize that the treatment is very early-stage and report a two-month waitlist.

The conversation covers stem-cell collection and future possibilities. One speaker recalls a bone-marrow procedure performed while awake with local anesthetic; the other says cells can also be collected using medication and an IV. Researchers are working on reprogramming stored cells into more youthful cells with additional capabilities.

They discuss the possibility of growing organoids and heart tissue from a person’s stem cells as a future alternative to heart transplants. The topic raises ethical questions about growing body parts and whether consciousness could extend beyond the brain. The discussion closes with a House of Evolution promotion and the hope that currently expensive treatments will become more widely available.